CROI 2025 Abstract eBook

Abstract eBook

Search Term Index

HIV-2 369, 562 HIV-specific CD8 response 142, 145, 146, 347, 403, 405, 408, 412, 444, 447, 456, 486, 502, 972 HIV and COVID 129, 918, 921, 923, 931, 1097, 1099, 1324 HIV assays 568, 569, 1188 HIV assembly 134 HIV awareness 1151 HIV clade 1153 HIV coinfection 110, 139, 396, 440, 442, 637, 647, 666, 700, 779, 780, 1244, 1267 HIV complications 172, 176, 177, 599, 637, 822, 901, 915 HIV control 145, 404, 464, 487, 494, 499, 502, 541, 1042, 1227, 1316 HIV cure research 105, 144, 366, 485, 493, 503, 510, 512, 520, 527, 536, 537, 545, 550, 551, 577, 578, 1036, 1038 HIV detection 554, 1080, 1128 HIV diagnosis 636, 1098, 1127, 1177, 1184, 1198 HIV disclosure 1060, 1143 HIV DNA 169, 349, 350, 495, 560 HIV elite controllers 464, 495, 496, 497, 1042 HIV evolution 305 HIV exposed uninfected 1024, 1069 HIV exposed uninfected infants 458, 1019, 1021, 1026, 1027, 1028, 1029, 1045 HIV immunotherapy 106, 307, 406, 410, 427, 429, 447, 456, 457, 461, 462 HIV incidence 126, 1005, 1116, 1121, 1122, 1123, 1124, 1130, 1145 HIV infection 135, 342, 368, 388, 395, 412, 504, 663, 706, 1083, 1094, 1125, 1157, 1244, 1332, 1358 HIV latency 136, 316, 517, 544, 548, 550, 552, 564, 573, 574, 575, 576, 579, 629 HIV latency reactivation 136, 519, 528, 529, 531, 556, 564, 576, 579 HIV monoclonal antibody 417, 641, 701 HIV pathogenesis 135, 345, 354, 358 HIV persistence 419, 514, 516, 545, 550, 556, 572 HIV positive status 1080 HIV prevention 120, 154, 191, 194, 307, 820, 1011, 1076, 1102, 1105, 1137, 1170, 1179, 1182, 1202, 1207, 1219, 1225, 1228, 1230, 1232, 1233, 1234, 1236, 1255, 1269, 1292, 1293, 1306, 1308, 1315, 1319, 1321, 1323, 1342, 1347, 1354 HIV primary care 189, 1308 HIV protease 134, 707 HIV reactivation 537, 577, 1030 HIV rebound 484, 488, 1040 HIV reservoir 102, 133, 134, 168, 317, 351, 419, 422, 496, 497, 498, 510, 513, 514, 518, 520, 522, 523, 527, 536, 540, 543, 547, 550, 554, 558, 561, 563, 567, 569, 570, 583, 587, 608, 630, 664, 665, 1030, 1032, 1033, 1034, 1035, 1036 HIV resistance genotype 123, 156, 342, 675, 699, 730, 731, 732, 733, 734, 736, 737, 742 HIV risk 1179, 1249, 1269 HIV RNA 100, 137, 195, 321, 349, 495, 525, 560, 628, 651, 672, 1198 HIV self-testing 1177, 1178, 1180, 1199, 1317, 1322 HIV surveillance 184, 1126, 1134, 1153, 1154 HIV testing 118, 959, 1118, 1128, 1141, 1143, 1148, 1178, 1179, 1180, 1181, 1183, 1186, 1189, 1192, 1193, 1195, 1216, 1255 HIV testing cascade 1085 HIV transmission 1153, 1154, 1157, 1207, 1221, 1295, 1300 HIV treatment 202, 639, 642, 661, 675, 699, 701, 706, 736, 1003, 1141, 1317, 1337, 1363 HIV treatment and prevention 184, 1048, 1301 HIV treatment self-efficacy 994 HIV vaccine 142, 144, 150, 407, 411, 426, 428, 430, 431, 432, 434, 435, 436, 437 HIV/HBV 769 HIV/HBV coinfection 109, 111, 667, 735, 769, HIV recency yield 1194 HIV replication 308, 614

772, 775, 777, 779 HIV/HCV coinfection 750, 753, 756 HLA 446, 468, 489, 499, 1031 Home-based 118, 1318 Homeless 691, 693, 880, 1304 Hope Act 854 Hormonal contraception 119, 199, 1254 Hormone 842, 1022 Hormone therapy 1350 Hospitalizations 815, 911, 1051 Host-pathogen interaction 343, 354 Host immune response 340, 371, 390, 414, 434, 459, 462, 465, 466, 481, 708, 720, 1041 Host restriction factor 315, 323, 325, 327, 329 Housing status 880, 1106, 1145 HPTN 084 1266 HPV 165, 792, 803, 805, 1261, 1262, 1263, 1264 HPV vaccine 165, 807, 1263 HSIL 808 HSV-2 1197 HTLV-1 398, 555 Human 131 Human immunodeficiency virus 101, 137, 415, 459, 535, 546, 638, 645, 766, 836, 849 Human papillomavirus virus 810, 1261, 1262 Humanized mice 378, 447, 501, 589 Humoral response 472, 480 Hybrid immunity 477 Hypermutation 348 Hypertension 189, 190, 625, 819, 820, 821, 822, 823, 826 IADLs 603 Ibalizumab 690, 697 Immigrant 693 Immune 1002 Immune-virologic response 111 Immune activation 138, 355, 423, 436, 465, 662, 664, 665, 870, 944 Immune cell 102 Immune cell phenotype 370, 430, 572, 834 Immune checkpoints 447, 456 Immune cytotoxic response 458 Immune escape mutations 774 Immune exhaustion 369, 405, 410, 548, 584, 756, 836 Immune function 373 Immune reconstitution 359, 955 Immune recovery 353, 941 Immune response 393, 398, 440, 941, 942, 1035 Immunity 718 Immunization 415, 437 Immunocompromised 310, 312, 714 Immunogenicity 426, 435, 438, 720, 807 Immunological nonresponders 351, 359, 360, 581 Immunology 106, 383, 404 Immunometabolism 360, 394, 410, 545, 577, 930 Immunosenescence 514, 930 Immunosuppression 479, 590 Immunotherapy 451 Impact 1312, 1325, 1333 Implementation science 188, 686, 993, 1310, 1315, 1343, 1347, 1352, 1353, 1356 Immunomodulation 492 Immunophenotype 556 IFN 327, 363 IFN-beta 725 IFN-gamma 377 IgA 420, 477 IL-15 444, 451, 581 IL-18 379 IL-1B 379, 470 IL-32 827 IL-6 379, 668 Imaging 466

Index of Concentration at the Extremes 1226 India 751, 1139, 1148, 1246 Induced 609 Infant 392, 1045 Infant growth 1021 Infants 458, 1248 Infants and pediatrics 121, 393, 1014, 1031,

Latent reservoir 539, 552, 555 Latent tuberculosis 962, 964, 967, 968, 969, 970, 972

Lateral flow assay 1214 Latin America 1347, 1355 LDL 851 Lean mass 758

1039, 1040, 1041, 1044, 1160 Infection-related cancer 799 Infectivity 320 Inflammaging 182, 866, 868

Lenacapavir 120, 138, 151, 154, 642, 656, 688, 690, 721, 727, 736, 738, 1229, 1230, 1353, 1362 Lentiviral vector 429 Lentivirus restriction 328, 329, 330 Lesion 1094 Lesotho 1314 Levonorgestrel 119 Life expectancy 1159 Lifespan 1140 Linkage and retention 1149, 1320 Linkage to ART and PrEP 1223 Linkage to care 1178 Lipid 1023 Lipid Nanoparticles 336, 503, 509 Lipidomics 760, 766, 834 Lipoatrophy 894 Lipohypertrophy 181, 862 Liver cirrhosis 778, 779 Liver decompensation 761 Liver disease 392, 762, 782 Liver fat 113 Liver fibrosis 760, 763 Liver steatosis 758, 760, 762, 764, 765, 766 Liver stiffness 753, 763 Liver transplant 480 LMIC 117, 1198 Long-acting 152, 153, 199, 640, 654, 674, 676, 678, 701, 724, 971 Long-acting drugs 654 Long-acting injectable 154, 191, 193, 196, 202, 372, 639, 640, 644, 654, 655, 675, 679, 680, 681, 682, 683, 684, 685, 688, 689, 690, 691, 692, 702, 705, 706, 710, 731, 1008, 1014, 1015, 1017, 1046, 1203, 1230, 1236, 1318, 1337, 1339, 1349, 1355, 1359, 1360, 1362 Long COVID 173, 335, 337, 475, 918, 919, 921, 922, 924, 925, 926, 927, 928, 929, 930, 932, 933, 934, 935, 936, 937, 939, 940, 942, 944, 945, 946, 947 Longitudinal study 372, 373, 407, 525, 1030, 1056, 1169 Lopinavir 669 Loss of control 494 Low- and middle-income country 765, 1186, 1246 Low-level viremia 100, 419, 671, 746, 804, 1057, 1172 Low CD4 910 LRA 559, 577, 1043 LTR 318, 587 Lumbar puncture 1242 Lung 1168 Lung cancer 786, 787 Lung disease 336, 375 Lymph node 137, 368, 391, 465, 466, 496, 521, 583 Lymphocyte 849 Lymphoid tissue 509 m6A 321 Macaque 338, 1283 Macaque model 103, 708 Machine learning 484, 594, 715, 944, 961, 1309, 1312, 1313 Macrophage 141, 308, 364, 372, 509, 519, 542, 580, 846, 1003 MAFLD 758 Magnetic resonance imaging 811, 875, 1068 Maintenance therapy 701 Long-term mortality 917, 1061 Long-term therapy 539, 566, 673

Inflammasome 134, 378, 389, 456, 614, 930 Inflammation 172, 331, 335, 337, 342, 352, 360, 376, 378, 381, 383, 384, 386, 387, 388, 492, 597, 630, 638, 662, 663, 664, 668, 837, 843, 848, 868, 869, 910, 914, 930, 932, 1052, 1070, 1071, 1072, 1073, 1074, 1075 Inflammatory response 332, 470 Influenza 481 Injectable 1354 Injection drug use 108, 755, 845, 948 Innate immune response 140, 311, 317, 334, 354, 380, 424, 430, 566 Innate immunity 450, 543, 550, 585 Innate lymphoid cells 369, 469 InSTI 152, 724, 732, 737, 765, 895, 898, 900 InSTI resistance 155, 156, 724, 732, 737, 1228 Insufficient sleep 617 Insulin resistance 897, 902, 903, 905 Insulin sensitivity 906 Intact HIV-1 DNA 561, 565, 569, 1034 Intact HIV genome 554 Integrase 324 Integrase inhibitor 152, 658, 998, 1299 Integrase strand transfer inhibitor 155, 804, 824, 826, 838, 903, 951 Integrated care 190 Integration 580 Integration site 497, 552 Intensification 672 Interferon 140, 354, 424 Interferon alpha 943 Interferon lambda 756 Interferon stimulated genes 334 Interleukin-15 512 Interruption in treatment (IIT) 121, 1309, 1331, 1334 Intersectionality 1142 Intervention 1181, 1320 Intervention program 604, 874 Intestine 376 Intracellular 450 Intrahost 313 Intramuscular 154 Intravenous 203 IP-10 1002 IPDA 351, 501, 534, 537, 562, 570 IRIS 952 ISGs 424 Islatravir 204A, 204B, 642, 736, 1233 Isoniazid 956, 957 Isoniazid preventive therapy 968, 970 Jail 1101, 1338 K18-hACE2 mice 336 Kaposi sarcoma 124, 790, 791, 792, 793, 794, 796, 800, 955 Kenya 1008, 1027, 1028, 1057, 1123, 1211, 1322 Key population 1125, 1246 Kidney function 857, 1066 Kidney transplantation 650, 854, 855, 856 KIR 468, 1031 KIR2D 468 Knowledge 821 KSHV 789, 791, 792, 793, 797 KwaZulu Natal 1013 Kynurenine pathway 837 Lamivudine 1048 Language 173 Latency reversal 319, 449, 527, 575, 579 Latency reversal agents 136, 528, 575, 576, 579 Latent HIV-1 reservoir 516, 517, 529, 559 Late presenters 658, 1133, 1157 Latency reservoir 136, 531, 573

Search Term Index

In-hospital mortality 974 In vitro 138, 309, 721, 728 In vivo efficacy 429 Inappropriate prescribing 147 Incarceration 948, 1217 Incidence 108 Incidence rate 1170

Malaria 396 Malawi 796 Male circumcision 1205 Mali 1320 Malignancy 800, 803, 907 Maraviroc 672

CROI 2025 488